Everolimus (Certican) in combination with neoral in pediatric renal transplant recipients: Interim analysis after 3 months

Transplantation Proceedings

Volumn 34, Issue 6, 2002, Pages 2209-2210

  Vester, U ^a   Kranz, B ^a   Wehr, S ^b   Boger, R ^b   Hoyer, P F ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; COTRIMOXAZOLE; CYCLOSPORIN A; DACLIZUMAB; EVEROLIMUS; PREDNISONE;

CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; GRAFT REJECTION; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LYMPHOCELE; MALE; MULTICENTER STUDY; PEDIATRIC SURGERY; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RECIPIENT; URINARY TRACT INFECTION;

ADOLESCENT; CHILD; CYCLOSPORINE; DRUG THERAPY, COMBINATION; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMAN; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PREDNISONE; SIROLIMUS; TIME FACTORS;

EID: 0036754444     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(02)03204-9     Document Type: Article

References (6)

1. Nashan B: Transplant Proc 33:3215, 2001.
2. Schuler W., Sedrani R., Cottens S., et al. Transplantation. 64:1997;36.
3. Cole O.J., Shehata M., Rigg K.M. Transplant Proc. 30:1998;2200.
4. Schuurman H.J., Cottens S., Fuchs S., et al. Transplantation. 64:1997;32.
5. Kahan B.D., Kaplan B., Lorber M.I., et al. Transplantation. 71:2001;1400.
6. Van Damme-Lombaerts R, Webb NJA, Hoyer PF, et al: Pediatr Transplant 6:147, 2002.